Page 50 – Clinical Laboratory int.

Exothera appoints new CEO to lead viral vector and nucleic acid production

, 23 October 2024/in E-News /by panglobal

Exothera, a GMP-certified contract development and manufacturing organisation (CDMO) specialising in viral vectors, RNA therapeutics, and vaccines, has announced the appointment of Cédric Volanti as its new Chief Executive Officer. The appointment, effective 8 October 2024, marks a significant milestone for the Belgian company as it seeks to strengthen its position in the biopharmaceutical manufacturing […]

Fujifilm Irvine Scientific expands life sciences portfolio, integrates key products from Fujifilm Wako Chemicals

, 23 October 2024/in E-News /by panglobal

Fujifilm Irvine Scientific, a provider of cell culture solutions for life science and medical markets, has announced an expansion of its product portfolio through alignment with its sister company, Fujifilm Wako Chemicals U.S.A., Corp. From 1 October 2024, Fujifilm Irvine Scientific will directly promote products from three divisions of Fujifilm Wako Chemicals –Lab Automation, Lab […]

Beckman Coulter and Scopio Labs expand partnership to include digital bone marrow analysis

, 23 October 2024/in E-News /by panglobal

Beckman Coulter, a prominent clinical diagnostics company, and Scopio Labs, a MedTech firm specialising in digital cell morphology solutions, have announced an expansion of their long-term partnership. The new agreement includes global distribution of Scopio’s Full-Field Bone Marrow Aspirate™ (FF-BMA) Application, which is CE-Marked for use with Scopio’s X100 and X100HT scanners.

Beckman Coulter and Scopio Labs Add World’s First Digital Bone Marrow Imaging and Analysis to Long-Term Partnership

, 16 October 2024/in E-News /by panglobal

Beckman Coulter, a clinical diagnostics leader, and Scopio Labs, a medtech company that develops digital cell morphology workflow solutions, today jointly announced expansion of its long-term partnership to include a global distribution agreement of Scopio’s Full-Field Bone Marrow Aspirate™ (FF-BMA) Application. Scopio’s X100 / X100HT with FF-BMA Application are CE-Marked.

An artist’s impression of the Lilly Medicine Foundry

Eli Lilly to invest $4.5 billion in integrated drug discovery and manufacturing facility

drug discovery, Eli Lilly, pharmaceutical, Research, 3 October 2024/in E-News /by panglobal

Eli Lilly and Company has announced plans for a $4.5 billion (£3.6 billion) facility that integrates pharmaceutical research and manufacturing. The Lilly Medicine Foundry, revealed on 2 October 2024, will aim to streamline drug discovery and production processes. This approach could significantly accelerate the journey from drug development through clinical trials to manufacturing.